Published date: 7/16/2026

Value Proposition: A miniaturized implantable electrochemical platform for continuous monitoring of metabolic biomarkers in deep tissue.

Technology Description

Researchers at Washington University in St. Louis have developed a minimally invasive, multi-analyte, electrochemical probe for the continuous monitoring of interstitial pH and K+, and semi-continuous monitoring of lactate as biochemical reporters on metabolic health. Existing techniques for monitoring metabolic biomarkers in tissue offer valuable insights but often feature limitations such as invasiveness, indirect measurements, or single-analyte focus. Non-invasive options like Doppler Ultrasound and NIRS provide useful data but lack comprehensive metabolic profiling capabilities. Arterial Blood Gas (ABG) analysis provides detailed metabolic data but is invasive and impractical for continuous monitoring.

This miniaturized electrochemical platform can be used to continuously assess tissue metabolism in real-time, directly addressing disruptions due to oxygen deficiency, trauma, or illness. By pairing a multielectrode assembly with advanced structural engineering, electrode optimization, and wireless communication protocols, it provides stable real-time biomarker quantification in diverse environments such as blood and muscle tissue.

Stage of Research

The technology is currently in the prototype stage. The device’s efficacy has been validated through benchtop and physiological measurements, demonstrating significant quantitative agreement with clinical gold standards when measuring circulating ion concentrations. Real-world validation in clinical settings is the next critical step.

Publications

• Kenneth E. Madsen et al., A miniaturized implantable electrochemical platform for continuous monitoring of metabolites in deep tissue.Sci. Adv.12,eadz8930(2026).DOI:10.1126/sciadv.adz8930

Applications

• Metabolic health

• Monitoring of metabolic biomarkers

Key Advantages

• High Precision: Provides accurate real-time monitoring of metabolic biomarkers, essential for early diagnosis and intervention

• Noninvasive Deployment: Minimizes patient discomfort and potential complications

• Wireless Communication: Facilitates real-time data collection and remote monitoring

• Versatile Applications: Can be used for flap monitoring, limb viability assessment, compartment syndrome monitoring, and other critical conditions

Patents
Patent pending

Related Web Links – Mitchell Pet Profile